PARP Inhibitors: Breast Cancer’s Breakthrough and Resistance
In recent years, poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the landscape of cancer therapy, particularly in the management of breast ...
Tag: PARP inhibitors in breast cancer
Tanshinone IIA Boosts Olaparib Killing Breast Cancer Cells
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!